| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.1 | 0.04 |